This opportunity is no longer accepting applications.
grant PAR-24-208
NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
This grant is intended to support the implementation of clinical trials in the field of musculoskeletal, rheumatic, and skin diseases. It requires a cooperative agreement and is structured in two phases: UG3 for initial implementation and UH3 for full implementation, contingent on meeting specific milestones. Researchers conducting these trials are expected to collaborate closely with the awar…
NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
Funding Source
Agency: National Institutes of Health
Sub-agency: National Institute of Arthritis and Musculoskeletal and Skin Diseases
Program: SBIR
Awards & funding
Award Ceiling: $250,000
Award Amount: $250,000
Dates
Opportunity Released: May 23, 2024
Open for Submission: May 23, 2024
Submission Deadline: March 4, 2027
Application Window Closes: March 4, 2027
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers